Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Molecular Imaging Homepage

Louisiana getting $14 million Center for Molecular Imaging and Therapy Increasing research opportunities, collaboration and radiopharmaceuticals

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

DOE transfers land to Coquí Pharma for isotope production facility Will be used primarily to produce Mo-99

Amyloid PET scans help with Alzheimer's clinical management New insights from the 11,000 patient IDEAS study

United Imaging's total-body PET scanner shows promise in four new studies Faster scans, lower dose and 'a level of detail never seen in PET'

NorthStar buys IBA electron accelerators for Mo-99 production Will increase production capacity and efficiencies

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Dennis Durmis MITA names chair of board of directors

DOE to cut Moly-99 deals with four US firms

by Thomas Dworetzky , Contributing Reporter
The DOE has finished its evaluations and picked four U.S. companies “to begin negotiations for potential new cooperative agreement awards.”

The winning applicants were among those responding to a “funding opportunity” to make Molybdenum-99 (Mo-99) without using highly-enriched uranium (HEU).

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

“Mo-99 is such a critical tool in healthcare. Doctors count on it every day,” said U.S. Secretary of Energy Rick Perry in the Department of Energy statement, adding, “this industry outreach helps to develop a reliable domestic supply of a vital medical isotope, reduce dependence on foreign imports, and bring new opportunity to the heartland.”

At present, the U.S. does not have a domestic commercial supply of Mo-99, and depends on importing it from foreign producers, mostly located in Europe, South Africa and Australia – or relying on a small amount created at DOE national laboratories.

The four U.S. firms about to begin negotiating include, NorthStar Medical Radioisotopes in Beloit, Wisconsin; SHINE Medical Technologies in Janesville, Wisconsin; Northwest Medical Isotopes in Corvallis, Oregon; and Niowave in Lansing, Michigan.

The funding available for the cooperative agreements could be as much as $15 million per company, with industry partners matching the awarded amounts.

DOE also funds, in its labs, work to advance the progress of Mo-99 production without HEU.

The challenge of producing Mo-99 without HEU is part of the worldwide challenge of production of the material by any means in the face of aging nuclear plants and growing demand.

In fact, in July, 2018, Congress was urged by SNMMI, OEMs, advocacy groups and nuclear medicine providers worldwide to provide money toward a domestic supply of Mo-99 in the U.S.

The group's letter called for the Subcommittee on Energy and Water Development to approve a provision in both the House of Representatives and Senate Fiscal Year 2019 Energy and Water Appropriation bills that would help fund production of Mo-99 as part of the National Nuclear Safety Administration’s medical isotope program.

“We are experiencing problems with international sources due to various technical reasons. Mo-99m and Tc-99m are used every day in the clinic, from cancer staging to the detection of cardiac disease to neurological evaluation,” Satoshi Minoshima, the president of the Society of Nuclear Medicine and Molecular Imaging and one of the signatories of the letter, told HCB News at the time. “It is critical for the U.S. to develop sustainable sources of Mo-99m so that we will not be reliant on foreign sources for a product that is essential to healthcare in the U.S.”
  Pages: 1 - 2 - 3 >>

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.